Health
COVID-19 vaccine is safe and triggers immune response in human trial – Medical News Today
A phase II clinical trial finds that a COVID-19 vaccine candidate is safe and induces an immune response. The researchers are planning a phase III trial.
According to a new study, a Chinese phase II clinical trial of a COVID-19 vaccine candidate has shown that it is safe and induces an immune response.
With over 15 million confirmed cases of the new coronavirus, SARS-CoV-2, and more than 624,000 COVID-19 deaths globally, scientists around the world are competing against time to fast-track the development of new treatments to combat the disease.
Globally, scientists are developing about 250 candidate vaccines against SARS-CoV-2 infection. Of th…
Continue Reading